Total Payments
$1.0M
2024 Payments
$167,339
Companies
15
Transactions
1,096
Medicare Patients
1,168
Medicare Billing
$84,025
Payment Breakdown by Category
Other$928,645 (91.7%)
Travel$48,521 (4.8%)
Food & Beverage$19,850 (2.0%)
Consulting$15,179 (1.5%)
Education$153.56 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $927,385 | 394 | 91.6% |
| Travel and Lodging | $48,521 | 354 | 4.8% |
| Food and Beverage | $19,850 | 332 | 2.0% |
| Consulting Fee | $15,179 | 10 | 1.5% |
| Honoraria | $1,260 | 1 | 0.1% |
| Education | $153.56 | 5 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $514,161 | 423 | $0 (2024) |
| Shire North American Group Inc | $157,152 | 219 | $0 (2019) |
| Regeneron Healthcare Solutions, Inc. | $80,776 | 139 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $74,494 | 88 | $0 (2021) |
| GENZYME CORPORATION | $66,361 | 82 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $56,530 | 55 | $0 (2024) |
| Grifols USA, LLC | $28,402 | 28 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $13,707 | 11 | $0 (2021) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $13,055 | 18 | $0 (2018) |
| Genentech USA, Inc. | $3,361 | 9 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $167,339 | 164 | GlaxoSmithKline, LLC. ($106,065) |
| 2023 | $192,681 | 219 | GlaxoSmithKline, LLC. ($146,747) |
| 2022 | $141,116 | 132 | GlaxoSmithKline, LLC. ($103,072) |
| 2021 | $143,393 | 128 | GlaxoSmithKline, LLC. ($88,545) |
| 2020 | $71,676 | 66 | GlaxoSmithKline, LLC. ($42,563) |
| 2019 | $88,226 | 103 | GlaxoSmithKline, LLC. ($27,171) |
| 2018 | $113,210 | 136 | Shire North American Group Inc ($56,224) |
| 2017 | $94,708 | 148 | Shire North American Group Inc ($84,922) |
All Payment Transactions
1,096 individual payment records from CMS Open Payments — Page 1 of 44
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $6,325.00 | General |
| 12/20/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,900.00 | General |
| Category: RESPIRATORY | ||||||
| 12/12/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Travel and Lodging | In-kind items and services | $60.00 | General |
| 12/12/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Travel and Lodging | In-kind items and services | $40.20 | General |
| 12/12/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $36.18 | General |
| Category: Immunology | ||||||
| 12/12/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Travel and Lodging | Cash or cash equivalent | $30.15 | General |
| Category: IMMUNOLOGY | ||||||
| 12/11/2024 | GlaxoSmithKline, LLC. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,900.00 | General |
| 12/11/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,950.00 | General |
| Category: IMMUNOLOGY | ||||||
| 12/11/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,300.00 | General |
| Category: RESPIRATORY | ||||||
| 12/10/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $18.03 | General |
| Category: IMMUNOLOGY | ||||||
| 12/06/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,932.00 | General |
| Category: Immunology | ||||||
| 12/06/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Travel and Lodging | Cash or cash equivalent | $3.35 | General |
| Category: Immunology | ||||||
| 12/05/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,900.00 | General |
| Category: RESPIRATORY | ||||||
| 12/05/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,900.00 | General |
| Category: IMMUNOLOGY | ||||||
| 12/05/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Travel and Lodging | Cash or cash equivalent | $227.80 | General |
| Category: RESPIRATORY | ||||||
| 12/05/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | Cash or cash equivalent | $29.79 | General |
| Category: RESPIRATORY | ||||||
| 12/04/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $30.32 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/21/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Travel and Lodging | In-kind items and services | $373.00 | General |
| 11/21/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Travel and Lodging | In-kind items and services | $249.11 | General |
| 11/21/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Food and Beverage | In-kind items and services | $124.99 | General |
| 11/19/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Travel and Lodging | Cash or cash equivalent | $220.56 | General |
| Category: IMMUNOLOGY | ||||||
| 11/19/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: IMMUNOLOGY | ||||||
| 11/19/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | Cash or cash equivalent | $59.71 | General |
| Category: IMMUNOLOGY | ||||||
| 11/12/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $23.90 | General |
| Category: IMMUNOLOGY | ||||||
| 11/08/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Travel and Lodging | In-kind items and services | $162.29 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 279 | 1,182 | $55,962 | $18,344 |
| 2022 | 8 | 322 | 1,415 | $51,258 | $22,505 |
| 2021 | 7 | 304 | 1,649 | $54,075 | $26,543 |
| 2020 | 6 | 263 | 1,067 | $37,529 | $16,634 |
Total Patients
1,168
Total Services
5,313
Medicare Billing
$84,025
Procedure Codes
27
All Medicare Procedures & Services
27 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 49 | 74 | $19,298 | $6,556 | 34.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 53 | 58 | $10,825 | $3,927 | 36.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 28 | 28 | $9,584 | $3,461 | 36.1% |
| 95004 | Test for allergy using allergenic extract | Office | 2023 | 28 | 864 | $10,368 | $2,850 | 27.5% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2023 | 62 | 69 | $5,175 | $1,375 | 26.6% |
| 96160 | Administration and interpretation of patient-focused health risk assessment | Office | 2023 | 59 | 89 | $712.00 | $175.13 | 24.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 74 | 96 | $15,456 | $8,560 | 55.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 49 | 49 | $11,858 | $6,192 | 52.2% |
| 95004 | Test for allergy using allergenic extract | Office | 2022 | 33 | 1,079 | $12,948 | $3,667 | 28.3% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2022 | 59 | 69 | $5,175 | $1,437 | 27.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 19 | 20 | $2,320 | $1,413 | 60.9% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2022 | 15 | 15 | $1,725 | $615.83 | 35.7% |
| 94727 | Test to determine lung volumes using gas dilution or washout | Office | 2022 | 15 | 15 | $1,200 | $467.33 | 38.9% |
| 96160 | Administration and interpretation of patient-focused health risk assessment | Office | 2022 | 58 | 72 | $576.00 | $152.74 | 26.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 70 | 94 | $15,134 | $9,345 | 61.7% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 46 | 46 | $11,142 | $5,264 | 47.2% |
| 95165 | Preparation and provision of single or multiple antigens for allergen immunotherapy | Office | 2021 | 12 | 353 | $6,858 | $4,558 | 66.5% |
| 95004 | Injection of allergenic extracts into skin, accessed through the skin | Office | 2021 | 31 | 985 | $11,820 | $3,407 | 28.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 37 | 41 | $4,530 | $2,591 | 57.2% |
| 94010 | Measurement and graphic recording of total and timed exhaled air capacity | Office | 2021 | 50 | 53 | $3,975 | $1,218 | 30.6% |
| 96160 | Administration and interpretation of patient-focused health risk assessment | Office | 2021 | 58 | 77 | $616.00 | $159.84 | 25.9% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 79 | 100 | $14,500 | $7,724 | 53.3% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 28 | 28 | $6,580 | $3,281 | 49.9% |
| 95004 | Injection of allergenic extracts into skin, accessed through the skin | Office | 2020 | 27 | 779 | $9,348 | $2,797 | 29.9% |
| 94010 | Measurement and graphic recording of total and timed exhaled air capacity | Office | 2020 | 50 | 55 | $4,125 | $1,447 | 35.1% |
About Dr. Steven Stryk, M.D
Dr. Steven Stryk, M.D is a Allergy & Immunology healthcare provider based in Canton, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/24/2005. The National Provider Identifier (NPI) number assigned to this provider is 1285637165.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Steven Stryk, M.D has received a total of $1.0M in payments from pharmaceutical and medical device companies, with $167,339 received in 2024. These payments were reported across 1,096 transactions from 15 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($927,385).
As a Medicare-enrolled provider, Stryk has provided services to 1,168 Medicare beneficiaries, totaling 5,313 services with total Medicare billing of $84,025. Data is available for 4 years (2020–2023), covering 27 distinct procedure/service records.
Ad
Practice Information
- Specialty Allergy & Immunology
- Location Canton, MI
- Active Since 05/24/2005
- Last Updated 07/11/2016
- Taxonomy Code 207RA0201X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1285637165
Products in Payments
- NUCALA (Biological) $330,818
- DUPIXENT (Biological) $123,019
- CUVITRU (Biological) $118,578
- AREXVY (Drug) $80,590
- CINRYZE (Drug) $71,405
- FASENRA (Drug) $70,163
- TRELEGY ELLIPTA (Drug) $70,006
- Xembify (Biological) $28,402
- HYQVIA (Biological) $12,779
- SPIRIVA RESPIMAT (Drug) $9,530
- DUPIXENT (Drug) $8,113
- AirDuo RespiClick (Drug) $4,160
- Xolair (Biological) $3,344
- AIRDUO (Drug) $3,136
- QVAR (Drug) $2,151
- ArmonAir Digihaler (Drug) $2,080
- ProAir Digihaler (Drug) $1,680
- FASENRA (Biological) $850.00
- PROAIR RESPICLICK (Drug) $500.00
- XOLAIR (Drug) $251.27
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Allergy & Immunology Doctors in Canton
Mrs. Erinn Gardner, Md, MD
Allergy & Immunology — Payments: $7,862
Allergy & Immunology $7,862
Steven Morman, Md, MD
Allergy & Immunology — Payments: $1,355
Allergy & Immunology $1,355
Murli Manohar, Md Phd, MD PHD
Allergy & Immunology — Payments: $123.67
Allergy & Immunology $123.67
Dr. Emily Wang, Md, MD
Allergy & Immunology — Payments: $56.70
Allergy & Immunology $56.70
Robert Berkowitz, Md, MD
Allergy & Immunology
Allergy & Immunology